Skip to main content
. Author manuscript; available in PMC: 2021 Apr 15.
Published in final edited form as: Bioconjug Chem. 2020 Mar 20;31(4):1144–1155. doi: 10.1021/acs.bioconjchem.0c00003

Figure 4.

Figure 4.

Pharmacokinetics of VCAMelid, BiVCAMelid, and VCAM/ALB8 in TNF-α injected mice. (a) Blood, (b) Spleen, and (c) Brain concentration vs time profile. PK studies were performed after injection of equimolar doses of monovalent (VCAMelid, 5 μg), bivalent (BiVCAMelid, 10 μg) and bispecific (VCAM/ALB8, 10 μg) nanobodies.